We speak to Fernando Andreu, CEO and Dr. Raphael Gruber, Medical Director of 2cureX. The company participated in the ESMO World Congress on Gastrointestinal Cancer 2022 and we get to learn more about the congress, current trends within the field and how 2cureX will exploit the knowledge and network received during the congress in the company’s continued commercialisation of IndiTreat®. We also learn more about Dr. Raphael Gruber, who just recently joined 2cureX.